Cargando…

Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru

OBJECTIVE: This study aimed to describe the results of inspection of clinical trials (CTs) and the feasibility of conducting inspections virtually in Peruvian Social Security hospitals during the pandemic of COVID-19. METHODS: This study described 25 CTs that were inspected during August 2021–Novemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Añazco, Percy, Urrunaga-Pastor, Diego, Soto-Ordoñez, Suly, Torres, Fernando, Dávila, Luis Manuel López, del Carpio Toia, Agueda Muñoz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044101/
https://www.ncbi.nlm.nih.gov/pubmed/36976455
http://dx.doi.org/10.1007/s43441-023-00503-7
_version_ 1784913291656560640
author Herrera-Añazco, Percy
Urrunaga-Pastor, Diego
Soto-Ordoñez, Suly
Torres, Fernando
Dávila, Luis Manuel López
del Carpio Toia, Agueda Muñoz
author_facet Herrera-Añazco, Percy
Urrunaga-Pastor, Diego
Soto-Ordoñez, Suly
Torres, Fernando
Dávila, Luis Manuel López
del Carpio Toia, Agueda Muñoz
author_sort Herrera-Añazco, Percy
collection PubMed
description OBJECTIVE: This study aimed to describe the results of inspection of clinical trials (CTs) and the feasibility of conducting inspections virtually in Peruvian Social Security hospitals during the pandemic of COVID-19. METHODS: This study described 25 CTs that were inspected during August 2021–November 2021. The data for the variables were obtained from the CT inspection database of the Social Security Sub-directorate of Regulation and Management of Health Research which includes minutes and inspection reports. We describe the characteristics of the CT included and findings during the inspections using relative and absolute frequencies. Likewise, we evaluated the feasibility of virtual inspection through a self-administered questionnaire. RESULTS: According to the findings of the inspection, 60% of CTs were on biological products, and 60% were focused on infectiology. Additionally, 64% of CTs were implemented in Lima, 52% were conducted in level IV health facilities, and 72% were funded by the pharmaceutical sector. The lack of submission of requested documents (16/25) and inadequate access to the internet (9/15) and source documents (4/15) were the primary observations during the inspection. Regarding the feasibility of virtual supervisions, most interviewees rated their understanding of instruction form as “normal” and its content as “adequate.” Similarly, in the virtual self-assessment matrix, a large proportion of interviewees rated comprehension as “normal” (7/15) and its content as “adequate” (13/15). The quality of the virtual supervision process was 8.6 ± 1.1 on a scale of 1–10. CONCLUSION: Discrepancies in records and failure to submit requested documents were the main observations. Most interviewees considered the material to be adequate and gave an overall good rating to the virtual inspection process.
format Online
Article
Text
id pubmed-10044101
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100441012023-03-28 Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru Herrera-Añazco, Percy Urrunaga-Pastor, Diego Soto-Ordoñez, Suly Torres, Fernando Dávila, Luis Manuel López del Carpio Toia, Agueda Muñoz Ther Innov Regul Sci Original Research OBJECTIVE: This study aimed to describe the results of inspection of clinical trials (CTs) and the feasibility of conducting inspections virtually in Peruvian Social Security hospitals during the pandemic of COVID-19. METHODS: This study described 25 CTs that were inspected during August 2021–November 2021. The data for the variables were obtained from the CT inspection database of the Social Security Sub-directorate of Regulation and Management of Health Research which includes minutes and inspection reports. We describe the characteristics of the CT included and findings during the inspections using relative and absolute frequencies. Likewise, we evaluated the feasibility of virtual inspection through a self-administered questionnaire. RESULTS: According to the findings of the inspection, 60% of CTs were on biological products, and 60% were focused on infectiology. Additionally, 64% of CTs were implemented in Lima, 52% were conducted in level IV health facilities, and 72% were funded by the pharmaceutical sector. The lack of submission of requested documents (16/25) and inadequate access to the internet (9/15) and source documents (4/15) were the primary observations during the inspection. Regarding the feasibility of virtual supervisions, most interviewees rated their understanding of instruction form as “normal” and its content as “adequate.” Similarly, in the virtual self-assessment matrix, a large proportion of interviewees rated comprehension as “normal” (7/15) and its content as “adequate” (13/15). The quality of the virtual supervision process was 8.6 ± 1.1 on a scale of 1–10. CONCLUSION: Discrepancies in records and failure to submit requested documents were the main observations. Most interviewees considered the material to be adequate and gave an overall good rating to the virtual inspection process. Springer International Publishing 2023-03-28 /pmc/articles/PMC10044101/ /pubmed/36976455 http://dx.doi.org/10.1007/s43441-023-00503-7 Text en © The Author(s), under exclusive licence to The Drug Information Association, Inc 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Herrera-Añazco, Percy
Urrunaga-Pastor, Diego
Soto-Ordoñez, Suly
Torres, Fernando
Dávila, Luis Manuel López
del Carpio Toia, Agueda Muñoz
Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title_full Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title_fullStr Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title_full_unstemmed Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title_short Results and Feasibility of the Virtual Inspection of Clinical Trials During Pandemic of COVID-19 in Peru
title_sort results and feasibility of the virtual inspection of clinical trials during pandemic of covid-19 in peru
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044101/
https://www.ncbi.nlm.nih.gov/pubmed/36976455
http://dx.doi.org/10.1007/s43441-023-00503-7
work_keys_str_mv AT herreraanazcopercy resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu
AT urrunagapastordiego resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu
AT sotoordonezsuly resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu
AT torresfernando resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu
AT davilaluismanuellopez resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu
AT delcarpiotoiaaguedamunoz resultsandfeasibilityofthevirtualinspectionofclinicaltrialsduringpandemicofcovid19inperu